A Home Visiting Program for Pregnant Youth to Promote Early Brain Development II

April 22, 2020 updated by: Guilherme Vanoni Polanczyk, MD PhD, University of Sao Paulo

The Effects Over Early Brain Development of a Nurse Home Visitation Program for Pregnant Youth and Their Families Living in a Poor Urban Area in São Paulo, Brazil II

Home visiting programs for pregnant women aiming to improve mother-infant relationship has received worldwide attention in the past 30 years. These programs are considered an important strategy to improve women's health during pregnancy, aside from improving child's birthing conditions and allowing parents access to tools which will nurture and properly stimulate their baby, thus promoting emotional and cognitive development. Objectives: The "Nurse home visitation program for pregnant youth" aims to promote infant´s healthy development, from pregnancy to the first months of life, in a high-risk population. Methods: Eighty young pregnant women aged between 14 and 21 years were randomly allocated to the intervention or to usual prenatal care program. The "Nurse home visitation program for pregnant youth" was developed based on Albert Bandura's theory of self-efficacy, on Urie Bronfenbrenner´s bioecological model, which recognizes the importance of individual and family inclusion in various contexts of social life, on John Bowlby and Mary Ainsworth evolutionary theories of attachment, which involves the care practitioner addressing issues such as environmental health, life course and parenting, bond between mother and infant, and infant´s social and cognitive development. Neuropsychomotor development will be assessed at 3, 6, 12 and 24 months using the Bayley Scale of Infant Development. Brain development will be assessed via electroencephalography at 6, 12 and 24 months.

Study Overview

Status

Unknown

Conditions

Study Type

Interventional

Enrollment (Actual)

167

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • São Paulo, Brazil, 05403010
        • Faculdade de Medicina da Universidade de Sao Paulo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 20 years (ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Low socioeconomic status
  • Mother's age between 14-19
  • Mother being a primapara
  • Gestation between the 8th and 16th week

Exclusion Criteria:

  • High-risk gestation
  • Mother's Intellectual, visual or auditory disability

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Nurse home visits
Nurse home visits biweekly.
The visitation program was elaborated based in the following theoretical principles: a) Albert Bandura's self-efficacy theory; b) Urie Brofenbrenner's bioecological theory, which recognizes the importance of the insertion of individuals in families in varied contexts of life in society; c) John Bowlby and Mary Ainsworth's attachment theory. The basic premises of the intervention are health care, environmental health, life course development, development of parenting ability, relationship with friends and family, and social service support.
NO_INTERVENTION: Usual care
Usual care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Neuropsychomotor Development During First Year of Life: Cognition
Time Frame: From 3 to 12 months of age
Complete child assessment with the Bayley Scale of Infant Development at 3, 6 and 12 months of age.
From 3 to 12 months of age
Change in Neuropsychomotor Development During First Year of Life: Receptive Language
Time Frame: From 3 to 12 months of age
Child assessment with the Bayley Scale of Infant Development.
From 3 to 12 months of age
Change in Neuropsychomotor Development During First Year of Life: Expressive Language
Time Frame: From 3 to 12 months of age
Child assessment with the Bayley Scale of Infant Development
From 3 to 12 months of age
Change in Neuropsychomotor Development During First Year of Life: Fine Motor
Time Frame: From 3 to 12 months of age
Child assessment with the Bayley Scale of Infant Development, fine motor scale.
From 3 to 12 months of age
Change in Neuropsychomotor Development During First Year of Life: Gross Motor
Time Frame: From 3 to 12 months of age
Child assessment with the Bayley Scale of Infant Development
From 3 to 12 months of age

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Child Brain Maturation
Time Frame: At 6 and 12 months
Assessment of brain wave patterns (alpha, gamma and theta frequencies) via electroencephalography (EEG).
At 6 and 12 months
Mother-child Attachment Biomarker
Time Frame: At 6 and 12 months
Assessment of event-related potential associated with child face recognition of the mother via electroencephalography (EEG).
At 6 and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Guilherme V Polanczyk, PhD, University of Sao Paulo

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

June 13, 2018

Primary Completion (ANTICIPATED)

June 1, 2022

Study Completion (ANTICIPATED)

June 1, 2022

Study Registration Dates

First Submitted

April 22, 2020

First Submitted That Met QC Criteria

April 22, 2020

First Posted (ACTUAL)

April 24, 2020

Study Record Updates

Last Update Posted (ACTUAL)

April 24, 2020

Last Update Submitted That Met QC Criteria

April 22, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 2016/22455-8

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Child Development

Clinical Trials on Home visiting Program for Young Pregnant Women

Subscribe